These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2467687)

  • 1. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix.
    Symonds RP; Burnett RA; Habeshaw T; Kaye SB; Snee MP; Watson ER
    Br J Cancer; 1989 Mar; 59(3):473-5. PubMed ID: 2467687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine).
    Soeters R; Bloch B; Levin W; Dehaeck CM; Goldberg G
    Gynecol Oncol; 1989 Apr; 33(1):44-5. PubMed ID: 2467844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables.
    Seoud M; Geara FB; Shamseddine A; Salem Z; Khalil A
    Eur J Gynaecol Oncol; 2003; 24(2):163-8. PubMed ID: 12701970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy prior to radical radiotherapy for stage III and IV carcinoma of the cervix.
    Symonds RP; Habeshaw T; Watson ER; Kaye SB
    Clin Radiol; 1987 May; 38(3):273-4. PubMed ID: 2438078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].
    Chauvergne J; Rohart J; Héron JF; Aymé Y; Berlié J; Fargeot P; George M; Lebrun-Jezekova D; Pigneux J; Chenal C
    Bull Cancer; 1990; 77(10):1007-24. PubMed ID: 2249011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study.
    Chang HC; Lai CH; Chen MS; Chao AS; Chen LH; Soong YK
    Gynecol Oncol; 1992 Feb; 44(2):182-8. PubMed ID: 1371978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy.
    Tan LT; Jones B; Green JA; Kingston RE; Clark PI
    Br J Radiol; 1996 Feb; 69(818):165-71. PubMed ID: 8785646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer.
    Singh KC; Agarwal A; Agarwal S; Rajaram S; Goel N; Agarwal N
    Gynecol Obstet Invest; 2004; 58(2):109-13. PubMed ID: 15192286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix.
    Rustin GJ; Newlands ES; Southcott BM; Singer A
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1205-11. PubMed ID: 2447933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina.
    Patton TJ; Kavanagh JJ; Delclos L; Wallace S; Haynie TP; Gershenson DM; Wharton JT; Bass S
    Gynecol Oncol; 1991 Jul; 42(1):54-9. PubMed ID: 1916511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma.
    Chang HC; Lai CH; Chou PC; Tseng CJ; Chang TC; Hsueh S; Ho YS; Soong YK
    Cancer Chemother Pharmacol; 1992; 30(4):281-5. PubMed ID: 1379522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine, and methotrexate.
    Rosenthal CJ; Khulpateea N; Boyce J; Mehrotra S; Tamarin S
    Cancer; 1983 Dec; 52(11):2025-30. PubMed ID: 6194875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.